Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

34.06 +0.03 (+0.10%)

Streaming Delayed Price Updated: 12:59 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 Next >

Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva’s Longstanding Heritage in the Management of Migraine

June 03, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

A Catch-Up Day ↗

June 01, 2021

OPEC had a virtual meeting about rising demand for oil and rising demand that oil companies cut their carbon footprint.

Via Talk Markets

3 Cheap Pharmaceutical Stocks to Grab Now ↗

May 28, 2021

The pharmaceutical industry has been the beneficiary of significant investor attention amid the COVID-19 pandemic as society turned to its products to fight the coronavirus.

Via Talk Markets

Good Times For Gold ↗

May 26, 2021

Gold is rising some more, in part as an alternative to crypto.

Via Talk Markets

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

Better Mood Day ↗

May 20, 2021

The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.

Via Talk Markets

The Companies Tackling A Global Health Crisis

May 20, 2021

Via FinancialNewsMedia

Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets

May 17, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Friday Of The Heavy Week ↗

May 14, 2021

There is nothing like a pending weekend to push Wall Street into recuperation and this worked today

Via Talk Markets

A Down Day ↗

May 12, 2021

The tech wreck continues because inflation will hurt the costly stock sector more than others.

Via Talk Markets

Heavy Global Erosion ↗

May 11, 2021

It is an everything-down day. Even the news is down because commenters are being careful.

Via Talk Markets

Gold Up Four Days In A Row ↗

May 10, 2021

The dollar is at a nearly 3 month low.

Via Talk Markets

Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference

May 10, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Calm Markets Day ↗

May 07, 2021

Despite seriously disappointing April jobless numbers, markets are gaining all the same.

Via Talk Markets

Understanding Teva Pharmaceutical Indus's Unusual Options Activity ↗

May 06, 2021

Understanding Teva Pharmaceutical Indus's Unusual Options Activity On Thursday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option...

Via Benzinga

Finns and Danes ↗

May 05, 2021

Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.

Via Talk Markets

Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report

May 05, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States

May 04, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021 ↗

May 04, 2021

Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,...

Via Benzinga

Monday Markets Unhinged ↗

May 03, 2021

Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.

Via Talk Markets

9 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

May 03, 2021

Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest...

Via Benzinga

Teva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting

May 03, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

Another Heavy News Day ↗

April 29, 2021

For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.

Via Talk Markets

Teva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States

April 29, 2021

From Teva Pharmaceutical Industries Limited

Via Business Wire

A Heavy News Day And Crypto ↗

April 28, 2021

Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today.

Via Talk Markets

Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

TEVA earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT ↗

April 28, 2021

Teva Pharmaceutical Industries Ltd’s (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers,...

Via Benzinga

What's Behind Teva's Mixed Q1 Results ↗

April 28, 2021

Increased competition for several of its top products continued to affect the drugmaker's performance in Q1.

Via The Motley Fool

Recap: Teva Pharmaceutical Q1 Earnings ↗

April 28, 2021

Shares of Teva Pharmaceutical Indus (NYSE:TEVA) rose 1.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 17.11...

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

Starting at $3.75/week.

Subscribe Today